Theragnostics
Learn about theragnostics, how it works, and its potential in metastatic breast cancer.
Spotlight on the Tigerlily Foundation & Breast Cancer Racial Disparities
Find out more about our newest partner, Tigerlily Foundation, and their new Clinical Trials Initiative.
Health Insurance for MBC
Learn about managing issues related to health insurance for people with MBC.
Atezolizumab Immunotherapy Is Withdrawn From FDA-Approval Process
Understand more about the change in approval for Atezolizumab (Tecentriq®) for TNBC.
Metastatic Trial Search: New Features
See what’s new on Metastatic Trial Search — and find a trial that’s right for you.
Metastatic Breast Cancer News from ASCO 2021
Click here for MBC-related research and reports from ASCO 2021.
FDA Fast Track
FDA Fast Track is a program to accelerate the development, review, and approval of new drugs to fill an unmet medical need. Read more about FDA Fast Track.
Cell-Based Therapies: A Type of Immunotherapy for MBC
What is the difference between CAR T-cell therapy, TCR therapy, TIL therapy, NK cell therapy, and Bria-IMT? Learn more here.
Cell-Based Therapies: A Type of Immunotherapy for MBC
What is the difference between CAR T-cell therapy, TCR therapy, TIL therapy, NK cell therapy, and Bria-IMT? Learn more here.
Black Breast Cancer & BRCA1/2 Mutations
Learn more about BRCA1/2 testing for Black women diagnosed with breast cancer and other related resources about Black & BRCA.